ArticleMolecular cancer therapeutics2022

Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers.

Francesca Zammarchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.